Home NDC 60505-3681-3 Carvedilol Phosphate
Product NDC 60505-3681
Requested package NDC 60505-3681-3
11-digit product format 605053681
Labeler code 60505
Product ID 60505-3681_69bbb7a7-deed-4c83-83ed-26b0c50beb1a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name carvedilol phosphate
Dosage form CAPSULE, EXTENDED RELEASE
Route ORAL
Labeler Apotex Corp.
Application NDA022012
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2017-11-09
Marketing end 2023-05-31
Substance CARVEDILOL PHOSPHATE
Active strength 80 mg/1
Pharmacologic classes Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022012-001 COREG CR CARVEDILOL PHOSPHATE 10MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 N022012-002 COREG CR CARVEDILOL PHOSPHATE 20MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 N022012-003 COREG CR CARVEDILOL PHOSPHATE 40MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 N022012-004 COREG CR CARVEDILOL PHOSPHATE 80MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022012-001 8101209 2025-09-11 Drug product 2012-02-21 N022012-001 8101209*PED 2026-03-11 Pediatric extension N022012-002 8101209 2025-09-11 Drug product N022012-002 8101209*PED 2026-03-11 Pediatric extension N022012-003 8101209 2025-09-11 Drug product N022012-003 8101209*PED 2026-03-11 Pediatric extension N022012-004 8101209 2025-09-11 Drug product N022012-004 8101209*PED 2026-03-11 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 176 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2006-10-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022012-001 COREG CR 10MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022012-002 COREG CR 20MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022012-003 COREG CR 40MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD, RS 2006-10-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022012-004 COREG CR 80MG CAPSULE, EXTENDED RELEASE / ORAL AB RLD 2006-10-20 2680178bc6a6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 164 observed states.
Observed Orange Book patent history# Patent history page 1 of 16 · 640 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N022012-001 8101209 2025-09-11 Drug product 2012-02-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-001 8101209*PED 2026-03-11 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-002 8101209 2025-09-11 Drug product c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-002 8101209*PED 2026-03-11 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-003 8101209 2025-09-11 Drug product c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-003 8101209*PED 2026-03-11 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-004 8101209 2025-09-11 Drug product c2088c7a36db…2026-10-15 13:18:30 2026-09 N022012-004 8101209*PED 2026-03-11 Pediatric extension c2088c7a36db…2026-09-14 22:38:34 2026-08 N022012-001 8101209 2025-09-11 Drug product 2012-02-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-001 8101209*PED 2026-03-11 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-002 8101209 2025-09-11 Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-002 8101209*PED 2026-03-11 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-003 8101209 2025-09-11 Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-003 8101209*PED 2026-03-11 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-004 8101209 2025-09-11 Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022012-004 8101209*PED 2026-03-11 Pediatric extension 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022012-001 8101209 2025-09-11 Drug product 2012-02-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-001 8101209*PED 2026-03-11 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-002 8101209 2025-09-11 Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-002 8101209*PED 2026-03-11 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-003 8101209 2025-09-11 Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-003 8101209*PED 2026-03-11 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-004 8101209 2025-09-11 Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022012-004 8101209*PED 2026-03-11 Pediatric extension caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022012-001 8101209 2025-09-11 Drug product 2012-02-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-001 8101209*PED 2026-03-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-002 8101209 2025-09-11 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-002 8101209*PED 2026-03-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-003 8101209 2025-09-11 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-003 8101209*PED 2026-03-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-004 8101209 2025-09-11 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022012-004 8101209*PED 2026-03-11 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-001 8101209 2025-09-11 Drug product 2012-02-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-001 8101209*PED 2026-03-11 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-002 8101209 2025-09-11 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-002 8101209*PED 2026-03-11 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-003 8101209 2025-09-11 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-003 8101209*PED 2026-03-11 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-004 8101209 2025-09-11 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022012-004 8101209*PED 2026-03-11 Pediatric extension 31067a03dcf5…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60505-3681-3 Carvedilol Phosphate 30 in 1 BOTTLE CAPSULE, EXTENDED RELEASE 30 12
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 60505-3681 CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 12 Legacy NDC, 1 package rows 20210916_bcfe4b84-500e-4b93-ba20-aa7c4297b0ae.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Coreg CR CARVEDILOL PHOSPHATE Waylis Therapeutics LLC d3625d78-6eb6-41fe-8f6f-664965c104c4 2025-04-25 Warnings, Adverse reactions Exact identifier application applno (NDA): 022012 application number: NDA022012
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 60505-3681-3 60505368103 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-3681-3) 2017-11-09 2023-05-31 No No Current